IADR Abstract Archives

Quality Evaluation of Tobacco Screening and Cessation by Dental Professionals

Objectives:
Tobacco screening and cessation by dental health care providers is an essential component in the promotion of good oral and general health. Although evidence-based information on tobacco screening and cessation is widely available, rates of patient screening for tobacco use and cessation interventions in dental offices remain low. With the expansion of electronic health records (EHRs) in dentistry, structured data is now available for quality measurement research and evaluation.
Methods: We implemented, adapted and tested the Meaningful Use Stage 2 Tobacco Measure, designed for medical offices, in three dental schools and a large dental accountable care organization. In the primary measure, an automated EHR query identified patients 18 years and older who were screened for tobacco use one or more times within 24 months and who received cessation counseling intervention if identified as a tobacco user. A sub-sample was manually reviewed to determine feasibility and validity of the automated query.
Results: Our study population included 143,870 patients across all four sites with 77.8-100% screened for tobacco use. A total of 18,118 patients were tobacco users and males showed higher rates of tobacco use than females. Rates for tobacco use among males ranged from 11.5% - 25.2% and for females 5.8% - 14.4% across all sites. When evaluating cessation intervention for tobacco users, 5,611 (3.2%) received a tobacco cessation intervention with significant differences among study sites.
Conclusions: Process-of-care quality measurement research can provide valuable information towards personalized and precision oral health care. Our results indicated that the majority of dental patients receive tobacco screening; however, tobacco cessation intervention rates need improvement. Using data from EHRs, dentistry can perform clinical quality evaluations, identify gaps and opportunities for improving patient care including rates of tobacco screening and tobacco cessation.
Division: AADR/CADR Annual Meeting
Meeting: 2018 AADR/CADR Annual Meeting (Fort Lauderdale, Florida)
Location: Fort Lauderdale, Florida
Year: 2018
Final Presentation ID: 1378
Abstract Category|Abstract Category(s): Oral Health Research
Authors
  • Neumann, Ana  ( The University of Texas Health Science Center at Houston - School of Dentistry , Houston , Texas , United States )
  • Kim, Aram  ( Harvard School of Dental Medicine , Boston , Massachusetts , United States )
  • Tokede, Oluwabunmi  ( Harvard School of Dental Medicine , Boston , Massachusetts , United States )
  • White, Joel  ( UCSF School of Dentistry , San Francisco , California , United States )
  • Walji, Muhammad  ( The University of Texas Health Science Center at Houston - School of Dentistry , Houston , Texas , United States )
  • Kalenderian, Elsbeth  ( UCSF School of Dentistry , San Francisco , California , United States )
  • Kumar, Shwetha  ( The University of Texas Health Science Center at Houston - School of Dentistry , Houston , Texas , United States )
  • Bangar, Suhasini  ( The University of Texas Health Science Center at Houston - School of Dentistry , Houston , Texas , United States )
  • Kookal, Krishna  ( The University of Texas Health Science Center at Houston - School of Dentistry , Houston , Texas , United States )
  • Obadan-udoh, Enihomo  ( UCSF School of Dentistry , San Francisco , California , United States )
  • Yansane, Alfa-ibrahim  ( UCSF School of Dentistry , San Francisco , California , United States )
  • Even, Joshua  ( Willamette Dental , Hillsboro , Oregon , United States )
  • Mullins, Joanna  ( Willamette Dental , Hillsboro , Oregon , United States )
  • Simmons, Kristen  ( Willamette Dental , Hillsboro , Oregon , United States )
  • Support Funding Agency/Grant Number: R01DE024166
    Financial Interest Disclosure: NONE
    SESSION INFORMATION
    Poster Session
    Oral Cancer and Tobacco-related Research, Biofilm, Visualization & Imaging
    Friday, 03/23/2018 , 03:45PM - 05:00PM
    TABLES
    Primary measure, tobacco screening and cessation intervention scores by gender at each site

    Site

    Male: Frequency
    (Measure Score; 95% CI)
    Female: Frequency
    (Measure Score; 95% CI)
    P-value

    Site 1

    Primary Measure Score

    65.1%; (63.3-66.9)77.6%; (76.2-78.9)<0.0001

    Tobacco Screening

    86.9%; (85.6-88.2)90.4%; (89.4-91.4)<0.0001

    Tobacco Use

    25.2%; (23.4-27.0)14.4%; (13.2-15.6)<0.0001

    Cessation Intervention

    1%; (0.2-1.8)2.1%; (0.8-3.4)0.16

    Site 2

    Primary Measure Score

    81.3%; (79.3-83.3)84.5%; (82.9-86.1)0.02

    Tobacco Screening

    90.8%; (89.3-92.3)91.8%; (90.1-93.0)0.34

    Tobacco Use

    11.6%; (9.9-13.3)7.9%; (6.6-9.2)0.0006

    Cessation Intervention

    23.7%; (17.0-30.4)31.4%; (23.6-39.2)0.15

    Site 3

    Primary Measure Score

    73.5%; (71.9-75.1)80.8%; (79.4-82.2)<0.0001

    Tobacco Screening

    79.3%; (77.8-80.8)79.9%; (78.5-81.3)0.54

    Tobacco Use

    11.5%; (10.2-12.8)5.8%; (4.9-6.7)<0.0001

    Cessation Intervention

    81.5%; (76.7-86.3)81.4%; (75.1-87.7)0.98

    Site 4

    Primary Measure Score

    84.7%; (84.4-85.0)90.1%; (80.9-90.3)<0.0001

    Tobacco Screening

    99.9%; (99.9-99.9)99.9%; (99.9-99.9)0.25

    Tobacco Use

    16.4%; (16.1-16.7)10.2%; (10.0-10.4)<0.0001

    Cessation Intervention

    27.4%; (26.5-28.3)35.6%; (34.5-36.7)<0.0001
    95% CI: Confidence Interval